| 000 | 01623 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250512211711.0 | ||
| 264 | 0 | _c19840530 | |
| 008 | 198405s 0 0 eng d | ||
| 022 | _a0361-5960 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSackmann Muriel, F | |
| 245 | 0 | 0 |
_aAlternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia. _h[electronic resource] |
| 260 |
_bCancer treatment reports _cApr 1984 |
||
| 300 |
_a581-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphoid _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aStatistics as Topic |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aSvarch, E | |
| 700 | 1 | _aPavlovsky, S | |
| 700 | 1 | _aBustelo, P | |
| 700 | 1 | _aGiuntoli, J | |
| 700 | 1 | _aVergara, B | |
| 700 | 1 | _aGaray, G | |
| 700 | 1 | _aEppinger-Helft, M | |
| 700 | 1 | _aKvicala, R | |
| 700 | 1 | _aDibar, E | |
| 773 | 0 |
_tCancer treatment reports _gvol. 68 _gno. 4 _gp. 581-6 |
|
| 999 |
_c6370343 _d6370343 |
||